Matrido, Rollyfe T.
HRN: 16-06-74 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/14/2023
CEFTRIAXONE 1G (VIAL)
08/14/2023
08/20/2023
IV
2g
OD
CAP MR
Checking Final Appropriateness
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes